Metastatic ovarian cancer exhibited enhanced concurrent expression of MSLN and CA125 which is a noteworthy correlation between the manifestation of MSLN and CA125 as markers and the cancer progression. The gene discussed is MSLN; the disease is ovarian carcinoma.